Aptevo Therapeutics Inc. Variable Lease, Cost
Aptevo Therapeutics Inc. (APVO) reported Variable Lease, Cost of $300.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2023-11-14
- Aptevo Therapeutics Inc. variable lease, cost for the quarter ending 2023-09-30 was $300.00K, a 50.00% increase year-over-year.
- Aptevo Therapeutics Inc. variable lease, cost for the quarter ending 2022-09-30 was $200.00K.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month |
|---|---|---|---|
| 2023-09-30 | $300.00K 10-Q · filed 2023-11-14 | $600.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $200.00K 10-Q · filed 2023-08-10 | ||
| 2022-09-30 | $200.00K 10-Q · filed 2023-11-14 | $600.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $400.00K 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |